{"id":5400,"date":"2014-02-19T15:50:48","date_gmt":"2014-02-19T14:50:48","guid":{"rendered":"http:\/\/blog.cofb.cat\/?p=5400"},"modified":"2014-02-19T15:50:48","modified_gmt":"2014-02-19T14:50:48","slug":"els-nous-anticoagulants-orals-en-que-hem-avancat","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/es\/2014\/02\/19\/els-nous-anticoagulants-orals-en-que-hem-avancat\/","title":{"rendered":"Los nuevos anticoagulantes orales: \u00bfen qu\u00e9 hemos avanzado?"},"content":{"rendered":"<p><b><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2013\/11\/Tertulies2-2.jpg\"><img fetchpriority=\"high\" decoding=\"async\" class=\"alignright  wp-image-4174\" alt=\"-FULLA A5\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2013\/11\/Tertulies2-2.jpg\" width=\"213\" height=\"302\" \/><\/a>El 26 de febrero tendr\u00e1 lugar una nueva Tertulia de actualidad centrada en el tema de los Anticoagulantes orales <span style=\"text-decoration: underline;\"><a href=\"http:\/\/www.cofb.org\/es\/web\/guest\/cursos\/?p_p_id=portletllistatactivitats_WAR_portletllistatactivitats_INSTANCE_Au9v&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_col_id=column-2&amp;p_p_col_pos=1&amp;p_p_col_count=2&amp;_portletllistatactivitats_WAR_portletllistatactivitats_INSTANCE_Au9v_strutsAction=%2Fview%2Fdetall&amp;_portletllistatactivitats_WAR_portletllistatactivitats_INSTANCE_Au9v_id=1031\" target=\"_blank\" rel=\"noopener\">[Inscr\u00edbete]<\/a><\/span>.<\/b> Juan Carlos Laguna, catedr\u00e1tico de farmacolog\u00eda -Unidad de Farmacolog\u00eda de la Facultad de Farmacia de la Universidad de Barcelona-, dar\u00e1 un repaso a las indicaciones terap\u00e9uticas de los anticoagulantes orales y las caracter\u00edsticas farmacol\u00f3gicas.<\/p>\n<p><span style=\"color: #808080;\">\u00a0<b>Cl\u00e1sicos versus Nuevos anticoagulantes orales<\/b><\/span><\/p>\n<p>Uno de los puntos centrales que el dr. Laguna tratar\u00e1 ser\u00e1 qu\u00e9 se ha avanzado con los nuevos anticoagulantes orales -m\u00e1s caros- respecto a los cl\u00e1sicos, qu\u00e9 indicaciones y qu\u00e9 mecanismos de acci\u00f3n diferentes tienen, as\u00ed como las ventajas que pueden suponer y en qu\u00e9 casos. La eficacia y seguridad en el tratamiento tambi\u00e9n ser\u00e1 una de las cuestiones de la que se hablar\u00e1 en la ponencia.<\/p>\n<p>El ciclo \u201cTertulias de actualidad\u201d, que organiza el Colegio por segundo a\u00f1o consecutivo, tiene tres objetivos: actualizar conocimientos e intercambiar experiencias entre especialistas m\u00e9dicos y farmac\u00e9uticos; dar una atenci\u00f3n farmac\u00e9utica con consejo asistido sobre medicamentos y problemas relacionados con salud; y capacitar al alumno para realizar intervenciones preventivas y de promoci\u00f3n en problemas de salud as\u00ed como que conozca los \u00faltimos avances en la investigaci\u00f3n cient\u00edfica.<\/p>\n<p><b>Consulte el programa de las Tertulias aqu\u00ed.\u00a0<span style=\"text-decoration: underline;\"><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2013\/11\/TERT\u00daLIES-DACTUALITAT-2013_2014-modificado.pdf\" target=\"_blank\" rel=\"noopener\">TERTULIAS DE ACTUALIDAD 2013 \u2013 2014<\/a><\/span><span style=\"text-decoration: underline;\"><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2013\/11\/TERT%C3%9ALIES-DACTUALITAT-2013_2014-3-docx-rev3.pdf\" target=\"_blank\" rel=\"noopener\"><br \/>\n<\/a><\/span><\/b><\/p>","protected":false},"excerpt":{"rendered":"<p>El 26 de febrero tendr\u00e1 lugar una nueva Tertulia de actualidad centrada en el tema de los Anticoagulantes orales [Inscr\u00edbete]. Juan Carlos Laguna, catedr\u00e1tico de farmacolog\u00eda -Unidad de Farmacolog\u00eda de la Facultad de Farmacia de la Universidad de Barcelona-, har\u00e1 un repaso de las indicaciones terap\u00e9uticas de los anticoagulantes orales y sus caracter\u00edsticas [\u2026]<\/p>","protected":false},"author":1,"featured_media":4944,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[57],"tags":[70],"class_list":["post-5400","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mon-collegial","tag-formacio"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Els nous anticoagulants orals: en qu\u00e8 hem avan\u00e7at? - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2014\/02\/19\/els-nous-anticoagulants-orals-en-que-hem-avancat\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Els nous anticoagulants orals: en qu\u00e8 hem avan\u00e7at? - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"El 26 de febrer tindr\u00e0 lloc una nova Tert\u00falia d\u2019actualitat centrada en el tema dels Anticoagulants orals [Inscriu-te]. Juan Carlos Laguna, catedr\u00e0tic de farmacologia -Unitat de Farmacologia de la Facultat de Farm\u00e0cia de la Universitat de Barcelona-, far\u00e0 un rep\u00e0s de les indicacions terap\u00e8utiques dels anticoagulants orals i les caracter\u00edstiques [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2014\/02\/19\/els-nous-anticoagulants-orals-en-que-hem-avancat\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-02-19T14:50:48+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/02\/19\/els-nous-anticoagulants-orals-en-que-hem-avancat\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/02\/19\/els-nous-anticoagulants-orals-en-que-hem-avancat\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Els nous anticoagulants orals: en qu\u00e8 hem avan\u00e7at?\",\"datePublished\":\"2014-02-19T14:50:48+00:00\",\"dateModified\":\"2014-02-19T14:50:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/02\/19\/els-nous-anticoagulants-orals-en-que-hem-avancat\/\"},\"wordCount\":231,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/02\/19\/els-nous-anticoagulants-orals-en-que-hem-avancat\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"Formaci\u00f3\"],\"articleSection\":[\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2014\/02\/19\/els-nous-anticoagulants-orals-en-que-hem-avancat\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/02\/19\/els-nous-anticoagulants-orals-en-que-hem-avancat\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2014\/02\/19\/els-nous-anticoagulants-orals-en-que-hem-avancat\/\",\"name\":\"Els nous anticoagulants orals: en qu\u00e8 hem avan\u00e7at? - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/02\/19\/els-nous-anticoagulants-orals-en-que-hem-avancat\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/02\/19\/els-nous-anticoagulants-orals-en-que-hem-avancat\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2014-02-19T14:50:48+00:00\",\"dateModified\":\"2014-02-19T14:50:48+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/02\/19\/els-nous-anticoagulants-orals-en-que-hem-avancat\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2014\/02\/19\/els-nous-anticoagulants-orals-en-que-hem-avancat\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/02\/19\/els-nous-anticoagulants-orals-en-que-hem-avancat\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/02\/19\/els-nous-anticoagulants-orals-en-que-hem-avancat\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Els nous anticoagulants orals: en qu\u00e8 hem avan\u00e7at?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Els nous anticoagulants orals: en qu\u00e8 hem avan\u00e7at? - Col\u00b7legi de Farmac\u00e8utics de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2014\/02\/19\/els-nous-anticoagulants-orals-en-que-hem-avancat\/","og_locale":"es_ES","og_type":"article","og_title":"Els nous anticoagulants orals: en qu\u00e8 hem avan\u00e7at? - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"El 26 de febrer tindr\u00e0 lloc una nova Tert\u00falia d\u2019actualitat centrada en el tema dels Anticoagulants orals [Inscriu-te]. Juan Carlos Laguna, catedr\u00e0tic de farmacologia -Unitat de Farmacologia de la Facultat de Farm\u00e0cia de la Universitat de Barcelona-, far\u00e0 un rep\u00e0s de les indicacions terap\u00e8utiques dels anticoagulants orals i les caracter\u00edstiques [&hellip;]","og_url":"https:\/\/novaorg.cofb.net\/2014\/02\/19\/els-nous-anticoagulants-orals-en-que-hem-avancat\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2014-02-19T14:50:48+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrito por":"wpAdminCofbOrg","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2014\/02\/19\/els-nous-anticoagulants-orals-en-que-hem-avancat\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2014\/02\/19\/els-nous-anticoagulants-orals-en-que-hem-avancat\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Els nous anticoagulants orals: en qu\u00e8 hem avan\u00e7at?","datePublished":"2014-02-19T14:50:48+00:00","dateModified":"2014-02-19T14:50:48+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2014\/02\/19\/els-nous-anticoagulants-orals-en-que-hem-avancat\/"},"wordCount":231,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2014\/02\/19\/els-nous-anticoagulants-orals-en-que-hem-avancat\/#primaryimage"},"thumbnailUrl":"","keywords":["Formaci\u00f3"],"articleSection":["M\u00f3n col\u00b7legial"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2014\/02\/19\/els-nous-anticoagulants-orals-en-que-hem-avancat\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2014\/02\/19\/els-nous-anticoagulants-orals-en-que-hem-avancat\/","url":"https:\/\/novaorg.cofb.net\/2014\/02\/19\/els-nous-anticoagulants-orals-en-que-hem-avancat\/","name":"Els nous anticoagulants orals: en qu\u00e8 hem avan\u00e7at? - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2014\/02\/19\/els-nous-anticoagulants-orals-en-que-hem-avancat\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2014\/02\/19\/els-nous-anticoagulants-orals-en-que-hem-avancat\/#primaryimage"},"thumbnailUrl":"","datePublished":"2014-02-19T14:50:48+00:00","dateModified":"2014-02-19T14:50:48+00:00","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2014\/02\/19\/els-nous-anticoagulants-orals-en-que-hem-avancat\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2014\/02\/19\/els-nous-anticoagulants-orals-en-que-hem-avancat\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/novaorg.cofb.net\/2014\/02\/19\/els-nous-anticoagulants-orals-en-que-hem-avancat\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2014\/02\/19\/els-nous-anticoagulants-orals-en-que-hem-avancat\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Els nous anticoagulants orals: en qu\u00e8 hem avan\u00e7at?"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"El 26 de febrer tindr\u00e0 lloc una nova Tert\u00falia d\u2019actualitat centrada en el tema dels Anticoagulants orals [Inscriu-te]. Juan Carlos Laguna, catedr\u00e0tic de farmacologia -Unitat de Farmacologia de la Facultat de Farm\u00e0cia de la Universitat de Barcelona-, far\u00e0 un rep\u00e0s de les indicacions terap\u00e8utiques dels anticoagulants orals i les caracter\u00edstiques [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/5400","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/comments?post=5400"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/5400\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/media?parent=5400"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/categories?post=5400"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/tags?post=5400"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}